Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Naia Rare Diseases Announces Clinical Trial Authorisation (CTA) to Initiate Clinical Trials of NB 1001 for Short Bowel Syndrome in the United Kingdom

Marketwired Wednesday, 15 November 2017 ()
RICHMOND, CA--(Marketwired - November 15, 2017) - Naia Rare Diseases, a biopharmaceutical company developing drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases today announced that it has received Clinical Trial Authorisation ("CTA") from the Medicine and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom to initiate a clinical trial of its long-acting GLP-1 agonist, NB 1001, in adult patients with SBS.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Immuron concludes promising fatty liver disease clinical study

Immuron Ltd (ASX:IMC, NASDAQ:IMRN) has concluded the phase II study of IMM‐124E for the treatment of NASH (non-alcoholic steatohepatitis), with the results...
Proactive Investors - BusinessAlso reported by •Marketwired

IntelGenx Submits Montelukast VersaFilm(TM) Clinical Trial Application With Health Canada

*SAINT-LAURENT, QUEBEC--(Marketwired - Nov. 9, 2017) -* IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), today announced that it has...
Marketwired - Press ReleasesAlso reported by •Business WireProactive Investors

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial Designed to Meet Requirements of Regulatory Filing in Japan

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial Designed to Meet Requirements of Regulatory Filing in Japan
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), a clinical-stage pharmaceutical company focused on the...
Business Wire - Press ReleasesAlso reported by •FinanzNachrichten.deMarketwired

VolitionRx Ltd hails "fantastic progress" in the third quarter

VolitionRx Ltd's (NYSEAMERICAN:VNRX) stock shot up on Friday morning as its president and chief executive hailed “fantastic progress” made in the third...
Proactive Investors - Business

CISCRP Study Reveals New Insights into Improving Global Public and Patient Engagement in Clinical Research

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit organization, today announced the release of the...
PRWeb - Press Releases

Summit Therapeutics to present pre-clinical data that reveals potential of DMD treatment

Drug discovery company Summit Therapeutics PLC (LON:SUMM) (NASDAQ: is set to present pre-clinical data from the University of Oxford highlighting the potential...
Proactive Investors - Business

Living Cell Technologies maps timeline to clinical results from Parkinson's trial

Living Cell Technologies Ltd (ASX:LCT) is preparing some highly anticipated results from the NTCELL Parkinson's disease clinical trial, which are expected on...
Proactive Investors - BusinessAlso reported by •Marketwired

Kadmon Initiates Phase 2 Placebo-Controlled Clinical Trial of Tesevatinib in Autosomal Dominant Polycystic Kidney Disease

Kadmon Initiates Phase 2 Placebo-Controlled Clinical Trial of Tesevatinib in Autosomal Dominant Polycystic Kidney Disease
NEW YORK--(BUSINESS WIRE)--Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a Phase 2 clinical trial of tesevatinib in...
Business Wire - Press Releases


You Might Like


Other recent news in Press Releases

The BOSTON Globe Names Acceleration Partners a Top Place to WorkNINJA BLENDER - SOLLUME ESTHÉ Distributor G&J Completes Venture Company Certification by Ministry of SMEs and Startups (MSS) in SOUTH KOREA
Encore Consumer Capital Announces Sale of Atlantic Aqua Farms to ONTARIO Teachers’Edgewater Networks Announces Partnership with Mia Distribution to Serve AUSTRALIA and New Zealand Markets
A.M. Best Maintains Under Review With Developing Implications Status for Credit Ratings of Macau LIFE INSURANCE Company LimitedBecome the Hero in Star Wars™ BATTLEFRONT™ II, Launching Across the Galaxy Today
Our Telekom to Roll Out First 4G/LTE Network and High-Speed BROADBAND in Solomon Islands with SES NetworksAlternative Rock Radio Returns to NEW YORK CITY with the Launch of ALT 92.3 FM
Datacomp Releases 2017 JLT Manufactured Home Community Rent, Occupancy Reports for Oregon, Washington & MINNESOTAGOLDEN Prospect Precious Metals Ltd : Net Asset Value(s)

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+